Day Gain | ||
Gain | ||
Market Val | ||
Costs | ||
Cash | ||
Portfolio | ||
Realized | ||
Dividend |
Better Dividend Stock: AbbVie or Johnson & Johnson? | news.google.com • |
(ABBV) Trading Advice | news.google.com • |
Better Dividend Stock: AbbVie or Johnson & Johnson? | fool.com • |
AbbVie (NYSE:ABBV) Trading Down 3.8% | news.google.com • |
AbbVie Inc. (NYSE:ABBV) Shares Sold by Bahl & Gaynor Inc. | news.google.com • |
3 Dividend Stocks to Buy and Hold for the Next Decade | fool.com • |
Date | For | Estimate | Reported | Surprise | surprise % |
---|---|---|---|---|---|
2024-04-26 | 2024-03 | 2.26 | 2.31 | 0.05 | 2.21% |
2024-02-02 | 2023-12 | 2.76 | 2.79 | 0.03 | 1.09% |
2023-10-27 | 2023-09 | 2.86 | 2.95 | 0.09 | 3.15% |
2023-07-27 | 2023-06 | 2.79 | 2.91 | 0.12 | 4.30% |
2023-04-27 | 2023-03 | 2.44 | 2.46 | 0.02 | 0.82% |
2023-02-09 | 2022-12 | 3.54 | 3.6 | 0.06 | 1.69% |
Date | Firm | Action | From | To |
---|---|---|---|---|
2023-10-10 | Morgan Stanley | Upgrade | Overweight | Overweight |
2023-09-28 | Raymond James | Upgrade | Outperform | |
2023-07-27 | Piper Sandler | Upgrade | Overweight | Overweight |
2023-07-24 | William Blair | Upgrade | Market Perform | |
2023-07-13 | HSBC | Upgrade | Buy | |
2023-07-10 | Morgan Stanley | Upgrade | Overweight | Overweight |
Date | Name | Relation | Quantity | Description |
---|---|---|---|---|
2024-02-28 | BUCKBEE KEVIN K | Officer | 6.98K | Sale |
2024-03-19 | DONOGHOE NICHOLAS | Officer | 55.90K | Sale |
2024-02-27 | GONZALEZ RICHARD A | Chief Executive Officer | 519.10K | Sale |
2024-02-14 | HUDSON THOMAS J | Officer | 127.90K | Stock Award(Grant) |
2024-02-28 | MICHAEL ROBERT A. | President | 98.65K | Sale |
2024-02-22 | REENTS SCOTT T. | Chief Financial Officer | 15.43K | Sale |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Vanguard Group Inc | 159.30M | 21.46B | 9.03% |
2023-06-29 | Blackrock Inc. | 139.16M | 18.75B | 7.88% |
2023-06-29 | State Street Corporation | 78.18M | 10.53B | 4.43% |
2023-06-29 | JP Morgan Chase & Company | 56.77M | 7.65B | 3.22% |
2023-06-29 | Capital International Investors | 43.15M | 5.81B | 2.44% |
2023-06-29 | Geode Capital Management, LLC | 34.95M | 4.71B | 1.98% |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Vanguard Total Stock Market Index Fund | 55.03M | 7.41B | 3.12% |
2023-06-29 | Vanguard 500 Index Fund | 42.01M | 5.66B | 2.38% |
2023-05-30 | Fidelity 500 Index Fund | 19.79M | 2.73B | 1.12% |
2023-08-30 | SPDR S&P 500 ETF Trust | 19.43M | 2.86B | 1.10% |
2023-09-29 | American Mutual Fund Inc | 17.76M | 2.65B | 1.01% |
2023-08-30 | iShares Core S&P 500 ETF | 16.50M | 2.43B | 0.93% |
Dividend | Date |
---|---|
1.55 | 2024-04-12 |
1.55 | 2024-01-15 |
1.55 | 2024-01-12 |
1.48 | 2023-10-12 |
1.48 | 2023-07-14 |
1.48 | 2023-07-13 |
-
NFA Guys!!!! LOOK into ATER !!! Look at the facts, Numbers are lined up & we own float SI is above 40% , 100% utilization for 72 days, we own the float, CTB is high, we just need volume, SQUEEZE bound to happen Join ATER discord n let us know ur new.HODL!! SQUEEZE PLAY!!! Just need volume!! Lookup AnonFtheHF vids on youtube or
DO YOUR OWN DD IF YOU DONT BELIVE, SEE FOR YOURSELF!!!!
Just a BULL sticking it to SHORTS/HF. Love ya’ll!!!Peace out brothers!! Ticker: ATER
NFA -
I hope it’s going down today to make few bucks
-
Buy back if goes above 146 otherwise cover 140
-
Shorted 143 let’s c
-
$ABBV Algo’s pushed it down on nothing of any concern. Now it’s bouncing
-
$ABBV This price is a gift. Total overreaction.
Amazing company with solid fundamentals -
-
-
Fwd pe 7.98 the ladies love botox $ABBV Pelosi stock just look at her forehead big dick energy here
-
N e americans here? Thx $ABBV
-
-
Can i short this? $ABBV
-
-
-
-
Strong EOY chart $ABBV
-
Bought $84. Sell $100. Will buy when it holds. Risk on means no defensives
-
$ABBV skincare & botox booming. Replaces passengers on planes. Todays headline: In pandemic travel bust, cargo shipments of Botox and cheese replace passengers for starving airlines: https://www.cnbc.com/2020/11/07/coronavirus-cargo-shipments-of-botox-and-cheese-replace-passengers-for-starving-airlines.html at home means people starring at their aging wrinkles
-
Omg im rich $ABBV thx u divvy plz pray 4 ddy he will cure ronas wisconsin, Pennsylvania
-
$ABBV im telling u north chicago is a dump. North Side Chicago is beautiful, but N. Chi, which is a suburb of Chicago is the end of the line where u do not want to get off the prayers 4 cures 🦽🦽
-
Better Dividend Stock: AbbVie or Johnson & Johnson?
news.google.com • -
(ABBV) Trading Advice
news.google.com • -
AbbVie (NYSE:ABBV) Trading Down 3.8%
news.google.com • -
AbbVie Inc. (NYSE:ABBV) Shares Sold by Bahl & Gaynor Inc.
news.google.com • -
ABBV Stock Earnings: AbbVie Beats EPS, Beats Revenue for Q1 2024
news.google.com • -
Why AbbVie Stock Stumbled Today Despite the Earnings Beat
news.google.com • -
Abbvie stock falls amid growing biosimilar competition
news.google.com • -
AbbVie Stock Dives Despite 'Firing On All Cylinders' In First Quarter
news.google.com • -
Why AbbVie Stock Stumbled Today Despite the Earnings Beat
news.google.com • -
ABBV Stock Earnings: AbbVie Beats EPS, Beats Revenue for Q1 2024
news.google.com • -
AbbVie Stock Falls As Company Warns of Continued Humira Sales Slump
investopedia.com • -
AbbVie (ABBV) Q1 2024 Earnings Call Transcript
news.google.com • -
AbbVie (ABBV) Q1 2024 Earnings Call Transcript
news.google.com • -
Interesting ABBV Put And Call Options For July 19th
news.google.com • -
ABBV Stock Earnings: AbbVie Beats EPS, Beats Revenue for Q1 2024
news.google.com • -
AbbVie Q1 report beats Street despite plunging Humira sales (NYSE:ABBV)
news.google.com • -
AbbVie Q1 report beats Street despite plunging Humira sales (NYSE:ABBV)
news.google.com • -
AbbVie off 3% despite quarterly beats, 2024 guidance raise
news.google.com • -
PCE In-Line to Warmer, Pre-Market Calms; ABBV Beats, XOM Misses
news.google.com • -
AbbVie (ABBV) Reports Q1 Earnings: What Key Metrics Have to Say
news.google.com • -
AbbVie (ABBV) Beats Q1 Earnings and Revenue Estimates
news.google.com • -
PCE In-Line to Warmer, Pre-Market Calms; ABBV Beats, XOM Misses
news.google.com • -
5 stocks to watch on Friday: XOM, CVX, ABBV and more
news.google.com • -
5 stocks to watch on Friday: XOM, CVX, ABBV and more
news.google.com • -
AbbVie (ABBV) Beats Q1 Earnings and Revenue Estimates
news.google.com • -
AbbVie (ABBV) Beats Q1 Earnings and Revenue Estimates
news.google.com • -
AbbVie (ABBV) Beats Q1 Earnings and Revenue Estimates
news.google.com • -
AbbVie (ABBV) Beats Q1 Earnings and Revenue Estimates
news.google.com • -
AbbVie (ABBV) Beats Q1 Earnings and Revenue Estimates
news.google.com • -
ABBV Stock Earnings: AbbVie Beats EPS, Beats Revenue for Q1 2024
news.google.com • -
AbbVie (ABBV) Outpaces Stock Market Gains: What You Should Know
news.google.com • -
What's in Store for These 5 Pharma Bigwigs in Q1 Earnings?
news.google.com • -
Dividend Growth Stars: 7 Stocks With 10-Year Double-Digit Rate Hikes
investorplace.com • -
ABBV (AbbVie) Book Value per Share
news.google.com • -
AbbVie (ABBV) to Report Q1 Earnings: What's in the Cards?
news.google.com • -
Dividend Aristocrats In Focus: AbbVie
news.google.com • -
20 Years To $300k? Building A $10,000 Dividend Portfolio From Scratch
seekingalpha.com • -
Steady Income, Steady Growth: 7 Blue-Chip Dividend Stocks to Buy Now
investorplace.com • -
Is AbbVie a Millionaire Maker?
fool.com • -
AbbVie: Bulletproof Fundamentals
seekingalpha.com • -
AbbVie: Despite The Run, Shares Still Look Attractive, Yielding 3.67%
seekingalpha.com • -
Wall Street Favorites: 3 Biotech Stocks With Strong Buy Ratings for April 2024
investorplace.com • -
AbbVie: Still Fits Buffett's 10x EBT Rule Well Despite Guidance Revision
seekingalpha.com • -
Passive Income Perfection: 7 Dividend Stocks to Generate $50,000 Per Year
investorplace.com • -
2 Strong Dividend Buys And 2 Sells For Q2 2024
seekingalpha.com • -
The 3 Best Stocks to Buy in April 2024
investorplace.com • -
10 Dividend Growth Stocks: March 2024
seekingalpha.com • -
AbbVie acquisition signals confidence in small-cap biotech sector's growth potential
proactiveinvestors.com • -
2 Top Dividend Stocks to Buy Hand Over Fist
fool.com • -
3 Must-Have Dividend Kings for a Steady Income Stream
investorplace.com • -
Trouble-Proof Dividend Darlings: 7 Stocks That Keep Paying No Matter What
investorplace.com •